These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21677331)

  • 1. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.
    Abu El Makarem MA; Abdel-Aleem A; Ali A; Saber R; Shatat M; Rahem DA; Sayed D
    Ann Hepatol; 2011; 10(3):296-305. PubMed ID: 21677331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
    Nabih MI; Aref WM; Fathy MM
    Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
    Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis.
    Abdel-Hafiz SM; Hamdy HE; Khorshed FM; Aboushousha TS; Safwat G; Saber MA; Seleem M; Soliman AH
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1021-1027. PubMed ID: 29693976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
    Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
    BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
    Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W
    Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
    Jang ES; Jeong SH; Kim JW; Choi YS; Leissner P; Brechot C
    PLoS One; 2016; 11(3):e0151069. PubMed ID: 26986465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.].
    Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
    Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis.
    Zhu M; Zheng J; Wu F; Kang B; Liang J; Heskia F; Zhang X; Shan Y
    J Med Virol; 2020 Dec; 92(12):3596-3603. PubMed ID: 32043608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of plasma osteopontin level in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
    El-Din Bessa SS; Elwan NM; Suliman GA; El-Shourbagy SH
    Arch Med Res; 2010 Oct; 41(7):541-7. PubMed ID: 21167394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.
    Li J; Chen X; Dai M; Huang S; Chen J; Dai S
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):543-553. PubMed ID: 28291627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
    Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
    PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
    Shang S; Plymoth A; Ge S; Feng Z; Rosen HR; Sangrajrang S; Hainaut P; Marrero JA; Beretta L
    Hepatology; 2012 Feb; 55(2):483-90. PubMed ID: 21953299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.
    Duarte-Salles T; Misra S; Stepien M; Plymoth A; Muller D; Overvad K; Olsen A; Tjønneland A; Baglietto L; Severi G; Boutron-Ruault MC; Turzanski-Fortner R; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Bamia C; Pala V; Palli D; Mattiello A; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez-Cantalejo E; Ardanaz E; Gavrila D; Dorronsoro M; Werner M; Hemmingsson O; Ohlsson B; Sjöberg K; Wareham NJ; Khaw KT; Bradbury KE; Gunter MJ; Cross AJ; Riboli E; Jenab M; Hainaut P; Beretta L
    Cancer Prev Res (Phila); 2016 Sep; 9(9):758-65. PubMed ID: 27339170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
    Abdel-Razik A; Elhelaly R; Elzehery R; El-Diasty A; Abed S; Elhammady D; Tawfik A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):599-605. PubMed ID: 26741637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.
    Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y
    J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.